School of Chemistry and Chemical Engineering, State Key Laboratory of Metal Matrix Composites, Shanghai Jiao Tong University, 800 Dongchuan Road, Shanghai, 200240, P. R. China.
Nat Commun. 2018 May 24;9(1):2053. doi: 10.1038/s41467-018-04318-1.
Cancer cells in hypoxic tumors are remarkably resistant to photodynamic therapy. Here, we hypothesize that an oxygen and Pt(II) self-generating multifunctional nanocomposite could reverse the hypoxia-triggered PDT resistance. The nanocomposite contains Pt(IV) and chlorin e6, in which upconversion nanoparticles are loaded to convert 980 nm near-infrared light into 365 nm and 660 nm emissions. Upon accumulation at the tumor site, a 980 nm laser is used to trigger the nanocomposite to generate O for consumption in the PDT process and to produce cytotoxic reactive oxygen species. The composite also releases active Pt(II) for synergistic photo-chemo therapy to enhance antitumor efficiency. The oxygen and Pt(II) self-generating prodrug is shown to have high potential to inhibit tumors out of the range of UV light, to overcome the hypoxia-triggered PDT resistance and significantly improve anticancer efficacy by the synergistic PDT-chemotherapy.
乏氧肿瘤中的癌细胞对光动力疗法具有显著的耐药性。在这里,我们假设一种可以自我产生氧气和铂(II)的多功能纳米复合材料可以逆转缺氧触发的 PDT 耐药性。该纳米复合材料包含铂(IV)和叶绿素 e6,其中上转换纳米颗粒被负载以将 980nm 近红外光转换为 365nm 和 660nm 发射。在肿瘤部位积累后,使用 980nm 激光触发纳米复合材料产生 O2 以消耗 PDT 过程中的氧气,并产生细胞毒性活性氧。该复合材料还释放活性铂(II)以进行协同光化疗,从而提高抗肿瘤效率。结果表明,这种氧气和铂(II)自我生成的前药具有在紫外线范围之外抑制肿瘤的巨大潜力,可克服缺氧触发的 PDT 耐药性,并通过协同 PDT-化疗显著提高抗癌疗效。